PATRICIA MBOLA: Open Payments
NPI 1962693523 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 29 payments from 5 companies in 2025. Trend: 2023 $956 · 2024 $564 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $219 |
| ACADIA Pharmaceuticals Inc | 5 | $204 |
| Neurocrine BioSciences, Inc. | 10 | $192 |
| Alkermes, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
Products named: REXULTI, NUPLAZID, INGREZZA, ARISTADA, AUSTEDO XR, UZEDY.
Industry payments across TX — which companies pay providers there.
